Skip to main content
Premium Trial:

Request an Annual Quote

When Boring Is Good

Getting your genome sequenced or getting genotyped is increasingly within reach for many people, including healthy people, and NBC News' Nancy Snyderman and some of her family members took a dive into their genetics. Snyderman underwent both 23andMe testing and Illumina sequencing.

"What's fascinating ... is that this is me, right here on a tablet," Snyderman tells an NBC colleague. "And as we learn more about what genes underlie specific diseases, I'll have this as a reference."

Scripps Health's Eric Topol and Robert Green from Brigham and Women's Hospital both caution that it is still early days for clinical genome sequencing. "As we roll out genomic medicine we are fighting against this society-wide misconception that having the bad gene means you're going to get the disease. That's only true in a very few cases," Green said.

Still, Anne Wojcicki from 23andMe notes that if people know their genetic information, that can help them manage their health."It's important for you to actually own your own data and be able to give it to your physician, give it to your insurance company, give it to others as you want," she adds. "But it's important for you to own it first."

As for Snyderman, she says that she found her genome to be "boring" — but that's a good thing.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.